Danhong Injection Alleviates Blood-Brain Barrier Disruption Caused by Cerebral Ischemia-Reperfusion Injury in <sub>5</sub>Hyperlipidemia Rats by Regulating the Wnt/β-Catenin Pathway.

Pharmaceuticals (Basel) · 2026 · PMC13028738 · PMID 41901285

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although Occludin expression also declined, the difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Danhong Injection Alleviates Blood-Brain Barrier Disruption Caused by Cerebral Ischemia-Reperfusion Injury in &lt;sub&gt;5&lt;/sub&gt;Hyperlipidemia Rats by Regulating the Wnt/β-Catenin Pathway.

The sentences

Danhong Injection Alleviates Blood-Brain Barrier Disruption Caused by Cerebral Ischemia-Reperfusion Injury in <sub>5</sub>Hyperlipidemia Rats by Regulating the Wnt/β-Catenin Pathway.